NEPHNephros, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · nephros.com

4.080USD-14.29%Mkt Cap: 44.31M $P/E: 27.203d ago

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap44.31M $

Enterprise Value44.01M $

Revenue (TTM)20.72M $

Gross Profit11.63M $

Net Income (TTM)1.19M $

Revenue/Share1.939 USD

Last Price4.080 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees36

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)27.20

P/E (Forward)20.98

PEG—

EV/EBITDA24.96

EV/Revenue2.12

P/S2.31

P/B4.00

EPS (TTM)0.15

EPS (Forward)0.21

52W Range

2.66038% of range6.420

52W High6.420 USD

52W Low2.660 USD

Profitability

Gross Margin61.87%

Oper. Margin20.16%

EBITDA Margin8.51%

Profit Margin6.35%

ROE11.70%

ROA8.75%

Growth

Revenue Growth36.20%

Earnings Growth450.00%

Cash Flow & Leverage

Operating CF1.65M $

CapEx (TTM)—

FCF Margin-7.00%

FCF Yield-3.28%

Net Debt-3.83M $

Net Debt/EBITDA-2.17

Balance Sheet

Debt/Equity0.10

Current Ratio4.07

Quick Ratio2.63

Book Value/Sh1.102 USD

Cash/Share0.4320 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJul 10, 2019

Splits

Last Split1:9

Split DateJul 10, 2019

Analyst Consensus

Rating2.0 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)6.250 USD

Upside (mean)+53.2%

Target Range4.750 USD – 8.000 USD

$4.750+53.2% to mean$8.000

# Analysts3

Ownership

Shares Out.10.86M

Float9.41M

Insiders12.89%

Institutions48.93%

Short Interest

Short Ratio4.2d

Short % Float0.56%

Short % Out.0.35%

Shares Short37.49K

Short (prev mo.)31.81K

Technical

SMA 503.665 (+11.3%)

SMA 2003.941 (+3.5%)

Beta1.52

S&P 52W Chg18.16%

Avg Vol (30d)19.95K

Avg Vol (10d)35.34K

Technical Indicators

RSI (14)52.2

MACD0.2520

MACD Signal0.2049

MACD Hist.+0.0471

BB Upper4.898 USD

BB Middle3.922 USD

BB Lower2.945 USD

BB Width49.81%

ATR (14)0.4013 USD

Vol Ratio (20d)4.59x